Expert IND-enabling studies for drug development
Get a comprehensive preclinical testing program that prepares and supports your molecule or new modality through IND-enabling studies and application submission. We provide fully integrated programs that address the bioanalytical, DMPK, and toxicology testing needs of your candidate and meet the demands of your IND submission timeline.
Tell us more about your compound by filling out the form on the right and one of our experts will be in touch
600+
IND Enabling Packages
200+
NDA Enabling Packages
2k+
Molecules Evaluated in Pre-Formulation Studies
4.5k+
Safety Assessment Studies since 2011
15k+
in vivo Studies per Year
Advance your candidate further, faster
We combine world-class drug development testing with cross-functional program management and global regulatory expertise to shepherd your candidate through IND submission—saving you significant time and expense.
Bioanalysis
DMPK
Toxicology
Pharmacology
CMC
Regulatory Affairs
Your end-to-end preclinical testing partner
With capabilities in safety assessment, DMPK/ADME, bioanalytical, pharmacology, Chemistry, Manufacturing and Controls (CMC) and analytical services all under one roof, WuXi AppTec is a global expert in preclinical development testing and can support the full scope of your development program, from discovery to IND-enabling studies to NDA submission.